Reports for PHARMASCIENCE INC
Company Name
PHARMASCIENCE INC
Totals |
||
Shortage reports |
1238 |
|
Actual shortage: | 50 (4%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 36 (3%) | |
Resolved: | 1152 (93%) | |
Discontinuation Reports |
284 |
|
To be discontinued: | 0 (0%) | |
Discontinued: | 283 (100%) | |
Reversed: | 1 (0%) | |
Late reports |
205 (13%) |
|
Overdue reports |
6 (12%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
PMS-BUPRENORPHINE-NALOXONE | 8MG 2MG | TABLET | Resolved | 2017-08-01 | 2017-11-23 | 17805 |
PMS-BUPRENORPHINE-NALOXONE | 8MG 2MG | TABLET | Resolved | 2019-05-09 | 2019-07-30 | 83732 |
PMS-BUPRENORPHINE-NALOXONE | 8MG 2MG | TABLET | Resolved | 2019-06-28 | 2019-07-30 | 88025 |
PMS-BUPRENORPHINE-NALOXONE | 8MG 2MG | TABLET | Resolved | 2019-10-04 | 2022-01-17 | 95445 |
PMS-ENALAPRIL | 8MG | TABLET | Resolved | 2017-03-13 | 2020-04-02 | 1860 |
PMS-ENALAPRIL | 8MG | TABLET | Resolved | 2017-03-13 | 2020-04-02 | 1869 |
PMS-GALANTAMINE ER | 8MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2017-04-07 | 2018-02-17 | 6129 |
PMS-GALANTAMINE ER | 8MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2017-06-23 | 2018-02-17 | 13703 |
PMS-CANDESARTAN | 8MG | TABLET | Resolved | 2017-10-12 | 2018-04-19 | 25743 |
PMS-CANDESARTAN | 8MG | TABLET | Resolved | 2018-02-12 | 2018-03-07 | 39510 |
PMS-CANDESARTAN | 8MG | TABLET | Resolved | 2018-04-20 | 2018-07-13 | 46689 |
PMS-CANDESARTAN | 8MG | TABLET | Resolved | 2018-10-03 | 2019-02-08 | 63047 |
PMS-CANDESARTAN | 8MG | TABLET | Resolved | 2018-10-03 | 2019-02-08 | 63054 |
PMS-GALANTAMINE ER | 8MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-03-04 | 2021-10-15 | 77459 |
PMS-GALANTAMINE ER | 8MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-03-28 | 2021-10-15 | 79789 |
PMS-CANDESARTAN | 8MG | TABLET | Resolved | 2019-03-29 | 2019-06-11 | 79847 |
PMS-CANDESARTAN | 8MG | TABLET | Resolved | 2019-07-05 | 2020-10-26 | 88585 |
PMS-SILODOSIN | 8MG | CAPSULE | Resolved | 2023-08-10 | 2023-08-28 | 201556 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
PMS-ELETRIPTAN | 20MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117933 |
PMS-AMPHETAMINES XR | 20MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-15 | 2021-10-27 | 117945 |
PMS-OMEPRAZOLE DR | 20MG | TABLET (DELAYED-RELEASE) | Discontinued | 2020-06-17 | 2020-06-17 | 118117 |
PMS-OMEPRAZOLE DR | 20MG | TABLET (DELAYED-RELEASE) | Discontinued | 2020-06-17 | 2020-06-17 | 118120 |
PMS-OMEPRAZOLE DR | 20MG | TABLET (DELAYED-RELEASE) | Discontinued | 2020-06-17 | 2020-06-17 | 118123 |
ATORVASTATIN | 20MG | TABLET | Discontinued | 2020-07-23 | 2020-07-23 | 120976 |
ATORVASTATIN | 20MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137989 |
ATORVASTATIN | 20MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137992 |
SOFLAX SYRUP 4MG/ML | 20MG | SYRUP | Discontinued | 2021-04-23 | 2021-04-23 | 138006 |
PMS-DOCUSATE SODIUM | 20MG | SYRUP | Discontinued | 2021-06-21 | 2021-06-21 | 141302 |
PMS-DOCUSATE SODIUM | 20MG | SYRUP | Discontinued | 2021-11-16 | 2021-11-16 | 149365 |
PMS-OLMESARTAN | 20MG | TABLET | Discontinued | 2021-11-16 | 2021-11-16 | 149385 |
PMS DOCUSATE-CALCIUM CAP 240MG USP | 240MG | CAPSULE | Discontinued | 2020-06-15 | 2021-10-27 | 117707 |
PMS-VERAPAMIL SR | 240MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2020-06-15 | 2021-10-27 | 117766 |
PMS-DILTIAZEM CD | 240MG | CAPSULE (CONTROLLED-DELIVERY) | Discontinued | 2020-06-16 | 2020-06-16 | 118020 |
PMS-DILTIAZEM CD | 240MG | CAPSULE (CONTROLLED-DELIVERY) | Discontinued | 2020-06-16 | 2020-06-16 | 118023 |
PMS-GALANTAMINE ER | 24MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-10-15 | 2021-10-15 | 147347 |
PMS-GALANTAMINE ER | 24MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-10-15 | 2021-10-15 | 147352 |
PMS-LEVOFLOXACIN | 250MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6057 |
PMS-VALPROIC ACID | 250MG | CAPSULE | Discontinued | 2017-10-27 | 2017-10-27 | 27377 |